Go Local Guru Web Search

Search results

1. Results from the Go Local Guru Content Network

2. Beta decay - Wikipedia

   en.wikipedia.org/wiki/Beta_decay

   The two types of beta decay are known as beta minus and beta plus. In beta minus (β − ) decay, a neutron is converted to a proton, and the process creates an electron and an electron antineutrino ; while in beta plus (β + ) decay, a proton is converted to a neutron and the process creates a positron and an electron neutrino. β + decay is ...

3. Interferon beta-1b - Wikipedia

   en.wikipedia.org/wiki/Interferon_beta-1b

   Interferon beta-1b is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS). It is approved for use after the first MS event. Closely related is interferon beta 1a, also indicated for MS, with a very similar drug profile.

4. Positron emission - Wikipedia

   en.wikipedia.org/wiki/Positron_emission

   Positron emission, beta plus decay, or β + decay is a subtype of radioactive decay called beta decay, in which a proton inside a radionuclide nucleus is converted into a neutron while releasing a positron and an electron neutrino (ν e). Positron emission is mediated by the weak force.

5. AOL Mail

   mail.aol.com

   Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

6. Peter Cat Recording Co. Announces New Album ‘Beta,’ Plus ...

   www.aol.com/peter-cat-recording-co-announces...

   May 9, 2024 at 1:35 PM. Peter Cat Recording Co. has announced a new album, “Beta,” out Aug. 9 via Muddy Water. The first single will arrive May 16, as the band announced headlining tour dates ...

7. Interferon - Wikipedia

   en.wikipedia.org/wiki/Interferon

   Interferon beta-1a and interferon beta-1b are used to treat and control multiple sclerosis, an autoimmune disorder. This treatment may help in reducing attacks in relapsing-remitting multiple sclerosis and slowing disease progression and activity in secondary progressive multiple sclerosis.